Biotheranostics, Inc.

Addgene is a nonprofit plasmid repository located in Watertown, Massachusetts. Addgene’s mission is to accelerate research and discovery by improving access to useful research materials and information. Addgene facilitates the sharing of high-quality scientific materials, research reproducibility, and open science by archiving and distributing DNA-based research reagents and associated data to scientists worldwide. Addgene’s repository contains over 70,000 plasmids, including special collections on CRISPR, fluorescent proteins, chemogenetics, optogenetics, and viral plasmids. All plasmids in Addgene’s repository were deposited by your scientific colleagues from around the world. There is no cost for scientists to deposit plasmids, which saves time and money associated with shipping plasmids themselves. All plasmids are fully sequenced for validation and sequencing data is openly available. Addgene also provides ready-to-use AAV and lentiviral preparations of commonly requested plasmids as a service to scientists. Addgene offers free online educational resources and protocols about molecular biology topics such as common vector backbones, cloning, CRISPR, AAV and lentivirus production, and science careers. These resources include the Addgene blog, eBooks, guides, videos, and a podcast series.

CellSight Technologies is a privately held molecular imaging company. Our mission is to discover, develop and commercialize PET (Positron Emission Tomography) imaging companion diagnostics for the development of therapies and the clinical management of patients.


CellSight was recently granted eIND approval for a novel probe to visualize activated T cells. [18F]F-AraG is a substrate for enzymes naturally over-expressed inside activated T cells which allows us to image the level of expression in living subjects with no alteration of the T cells. Imagine being able to provide an immuno-oncology patient with efficacy information within days versus the months required with current practices.

CellSight also has eIND approval on a reporter gene / PET probe combination that allows repeated imaging or engineered cells. The GSV1-tk reporter gene in conjunction with the [18F]FHBG PET probe has been used clinically to monitor therapeutic cell migration, proliferation and survival.

I invite you to visit our website for additional information: www.cellsighttech.com

EpigenDx was incorporated in 2006 as a genomic and epigenomic research company specializing in disease biomarker discovery, validation and molecular diagnosis, with an unmatched expertise in the field of DNA methylation analysis.

EpigenDx provides superior products and laboratory services for scientific researchers from academic, government and industrial communities from all over the world. Our commitment to quality reflects our desire and dedication to provide the best products and services to our customers. EpigenDx has extensive knowledge and expertise in Pyrosequencing, bisulfite sequencing, and various epigenomic research analysis techniques and methods stemming from our years of experience in the industry.

EpigenDx Lab Services include:
DNA Methylation
- Bisulfite Pyrosequencing: determine loci specific methylation and global methylation levels individual CpGs sites
- Targeted MethylSeq: determine methylation levels in multiple targeted regions at base pair resolution
Expression Analysis
- Gene and miRNA profiling using Affymetrix Gene Chip arrays
Mutation & SNP Analysis
- Quantative mutation analysis using Pyrosequencing for minor allele detection, allele specific expression
- 1.8 million SNPs and copy number changes using Affymetrix 6.0 Array

EpigenDx products include:
DNA Methylation Controls: low and high methylated genomic DNA for studying human, mouse, rat genes
Validated loci specific DNA methylation assays for multiple platforms including bisulfite sequencing, bisulfite Pyrosequencing, and realtime based PCR analysis. All assays are validated for PCR bias or preferential amplification.
Methylation Panels including Stem Cell Panel, Cancer Panel, Immunology Panel, and CNS Panel. They are designed for bisulfite sequencing analysis using either Pyrosequencing or NGS platforms.

Science makes things simple, we make research easy! Let Lamda Biotech be your source for high quality research products at a value price.

Lamda Biotech provides products and services for molecular biology, functional genomics, proteomics and gene therapy all backed by expert technical support.

As scientists, we understand the importance of maximizing research funding and private investor capital. Toward that goal, we offer a variety of special pricing programs for new customers, start-up research labs, and customers who purchase in bulk quantities. We look forward to exceeding your expectations for quality products and superior Technical Support.

For more information please visit our website https://www.lamdabio.com/

We are a reliable, self-sustaining computational chemistry company. We offer our software and expertise to both smaller biotech companies and big pharma, either as a CRO or as licensed software, for use in the preclinical stages of drug discovery.

Are you a biotech kicking off a new project, looking for rational computer-aided drug design (CADD) to accelerate your hit discovery? We use our own software tools and a structure-based approach to identify novel small molecules targeting any protein family.

Do you need diverse comp. chem. expertise, but only employ a small in-house team, or no team at all? When you hire us as a CRO, we source our entire team’s experience in areas including structure-based design, chemoinformatics, quantum mechanics, and molecular dynamics.

Do you struggle with third-party software, hidden license requirements, and missing features? We develop our own software for most applications, precluding the need to sign other agreements or to procure other tools. We can also adjust and enhance our procedures to accommodate different project workflows. Our software works on PC, Linux, and Mac and we will run demos and workshops.

Are you looking for a long-term partner with flexibility in how you collaborate? We construct our agreements on FFS or FTE bases and generally do not retain IP on your projects. We conduct feasibility studies before spending time and money on projects that are unlikely to be successful. We will provide reports, communicate regularly, and return any generated data.

James Talton, CEO of Alchem Laboratories says, “We reviewed multiple software packages and MFI ranked in the top 10. Adding in their service and expertise made them an excellent partner on our DOD project. We’re excited by the results thus far and will absolutely continue working with their team in the future.

Contact us to start your project today! Don't forget to follow us on Twitter @MolForecaster!
Find our testimonials and references on our website!